/newsroom/ en /newsroom/news/list/2023/09/11/closing-in-on-cure-for-common-leukaemia A groundbreaking leukaemia test can help identify patients who are strong candidates for lifelong treatment free remission (TFR) – meaning they are effectively cured of the disease. September 12 2023 Jessica Stanley /newsroom/news/list/2023/09/11/closing-in-on-cure-for-common-leukaemia /newsroom/news/list/2022/05/11/arthritis-drug-used-to-limit-antibiotics-in-blood-cancer-patients Researchers from the ³ÉÈË´óƬ and the Radboud University Medical Centre in the Netherlands have repurposed an arthritis drug to restrict the use of antibiotics in the treatment of side effects caused by blood cancer, including leukaemia, lymphoma and myeloma. May 12 2022 Lee Gaskin /newsroom/news/list/2022/05/11/arthritis-drug-used-to-limit-antibiotics-in-blood-cancer-patients /newsroom/news/list/2020/06/29/162-million-for-rare-cancer-research A ³ÉÈË´óƬ and SAHMRI study to test new treatments for a rare and neglected blood cancer, which has no known effective treatment, has been awarded $1,619,122 from the Federal Government’s Medical Research Future Fund (MRFF). June 29 2020 Cathy Parker /newsroom/news/list/2020/06/29/162-million-for-rare-cancer-research /newsroom/news/list/2019/12/12/major-breakthrough-for-leukaemia-treatment An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML). December 12 2019 Elisa Black /newsroom/news/list/2019/12/12/major-breakthrough-for-leukaemia-treatment